The Tarsus Group has increased its medical product portfolio by acquiring BodySite Digital Health, a digital patient care management and education platform.
The US-based business will join Tarsus Medical Group, enabling the department to further expand its digital product stack to healthcare professionals (HCP) and strengthen its subscription services.
The acquisition will accelerate Tarsus Medical’s omni-channel strategy for providing digital services and products, as well as its comprehensive on-site and virtual events and continuing medical education programs, especially in the department’s American Society of Anti-Aging Medicine (A4M) brand.
“This acquisition is a very exciting move for Tarsus. One of our focus is to expand our product range to reflect the digital development of the industries we serve,” said Douglas Emslie, CEO of Tarsus Group.
He added: “Through this acquisition, we are seeking to leverage Tarsus Medical’s reputation among medical professionals and our close ties with the U.S. healthcare industry to further develop BodySite and enable the business to reach new customers and markets. ”
A key driver of the U.S. healthcare industry is the shift from reactive treatment to preventive medicine. HCP is increasingly focusing on resolving patient problems before they arise and identifying precursors to inform patient care management. Therefore, HCP has also been turning to digital tools to facilitate the delivery and management of patient-based care, with more emphasis on daily treatment and monitoring outside the doctor’s office and hospital.
The pandemic has further promoted the transition to digital medical services and changed the way patients see doctors. Many services that were once provided in person are now generally replaced by telemedicine services more safely and effectively.
Founded in 2010, BodySite utilizes three core functions: remote patient monitoring solutions (RPM), telemedicine services and a powerful learning management system (LMS), as well as detailed care plans.
The functionality of the platform is highly valued by its subscribers. When the pandemic makes personal access difficult, many of them also rely on BodySite to continue monitoring and treating patients.
“We are very happy to join the Tarsus Group; BodySite founder and CEO John Cummings stated that this acquisition will allow us to provide healthcare providers who want to have a greater impact on the health of patients and improve their daily interaction with patients Provide better tools and functions. Digital health.
He added: “We are very looking forward to working with Tarsus to integrate our existing products into their medical ecosystem and expand our capabilities to continue our mission to better change doctors and their patients to solve health problems. The way.”
This question is used to test whether you are a human visitor and prevent automatic spam submission.
Post time: Jul-15-2021